Benefits of Moxibustion at the Guanyuan Acupoint for Women

Acupuncture or moxibustion at the Guanyuan (CV4) acupoint—a key lower abdominal point located three cun below the umbilicus on the anterior midline—has long been used in Traditional Chinese Medicine (TCM) to support women’s health. Clinical and observational evidence suggests that targeted stimulation of Guanyuan may help regulate menstrual function, alleviate dysmenorrhea, and improve symptoms associated with gynecological conditions such as polycystic ovary syndrome (PCOS) and menopausal vasomotor disturbances.

From a TCM perspective, Guanyuan is considered the “Sea of Qi” and a major reservoir of Yuan Qi—the body’s foundational vital energy. It is closely linked to the Ren Mai (Conception Vessel) and governs reproductive, urinary, and endocrine functions. Moxibustion—particularly warm, gentle heat applied to this point—is frequently employed to tonify Kidney Yang, strengthen Spleen Qi, and warm the Lower Jiao, thereby addressing patterns commonly seen in female patients presenting with cold-type infertility, chronic pelvic pain, or fatigue with cold intolerance.

Modern research supports some physiological correlates: studies using thermal imaging and functional MRI have observed increased local microcirculation and modulated autonomic nervous system activity following Guanyuan stimulation. Randomized controlled trials report statistically significant reductions in menstrual pain intensity and duration, improved ovarian blood flow, and enhanced luteal phase progesterone levels in women undergoing regular Guanyuan moxibustion as an adjunctive therapy.

It is important to emphasize that Guanyuan intervention should be administered by licensed practitioners trained in TCM diagnostics and needling safety. Contraindications include acute pelvic inflammatory disease, pregnancy (especially during the first trimester), and overlying skin infection or malignancy. As with any complementary modality, Guanyuan therapy is best integrated into a comprehensive care plan—not as a standalone replacement for evidence-based gynecologic evaluation or treatment.